Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...


Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)


Anturane (sulfinpyrazone) is indicated for the treatment of:

1. Chronic gouty arthritis

2. Intermittent gouty arthritis



200-400 mg daily in two divided doses, with meals or milk, gradually increasing when necessary to full maintenance dosage in one week.


400mg daily, given in two divided doses, as above. This dosage may be increased to 800 mg daily, if necessary, and may sometimes be reduced to as low as 200 mg daily after the blood urate level has been controlled. Treatment should be continued without interruption even in the presence of acute exacerbations, which can be concomitantly treated with phenylbutazone or colchicine. Patients previously controlled with other uricosuric therapy may be transferred to Anturane (sulfinpyrazone) at full maintenance dosage.


Tablets 100 mg round, white, scored (imprinted CIBA 41)

Bottles of 100                     NDC 0083-0041-30

Capsules 200 mg green (imprinted Anturane (sulfinpyrazone) 200 CIBA 168)

Bottles of 100                     NDC 0083-0168-30

Do not store above 86° F (30° C).

Dispense in tight container (USP).

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.